Dual bronchodilation and exacerbations of COPD.

about

An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?The Challenges of Precision Medicine in COPD.

P2860

Q47728819-67541049-AF8A-48D3-AFF6-6C55956957C5 Q47962475-B631B7B4-6002-4AEC-8E57-50C2651B9AAF

P2860

Dual bronchodilation and exacerbations of COPD.

Item

http://www.wikidata.org/entity/Q42384700

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Dual bronchodilation and exacerbations of COPD.

@en

Dual bronchodilation and exacerbations of COPD.

@nl

type

Item

label

Dual bronchodilation and exacerbations of COPD.

@en

Dual bronchodilation and exacerbations of COPD.

@nl

prefLabel

Dual bronchodilation and exacerbations of COPD.

@en

Dual bronchodilation and exacerbations of COPD.

@nl

P1476

Dual bronchodilation and exacerbations of COPD.

@en

P2093

Josuel Ora

http://www.w3.org/2001/XMLSchema#string

Mario Cazzola

http://www.w3.org/2001/XMLSchema#string

P2860

Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.

LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.

Global Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: an Asia-Pacific perspective.

Distribution of receptor targets in the lung.

The role of bronchodilator treatment in the prevention of exacerbations of COPD.

Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells.

Outcomes for COPD pharmacological trials: from lung function to biomarkers.

Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans

The short, the long and the "ultra-long": why duration of bronchodilator action matters in chronic obstructive pulmonary disease.

Non-neuronal cholinergic airway epithelium biology.

P304

2383-2386

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.21037/JTD.2016.08.92

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ermanno Puxeddu

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27746982

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

5059243

http://www.w3.org/2001/XMLSchema#string

Dual bronchodilation and exacerbations of COPD.

about

P2860

P2860

Dual bronchodilation and exacerbations of COPD.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932